Tata Mutual Fund launches Tata India Pharma and Healthcare Fund

Mutual Fund
Dec 4, 2015 by Advisorkhoj Team | Mutual Fund | 36 Downloaded

NFO period: 04th December – 18th December 2015

Highlights of the NFO:

  • Scheme type – An Open Ended Pharma and Healthcare Services Sector Scheme

  • Investment objective – The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.

  • Product suitability – The product is suitable for investors who are seeking long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharma & Healthcare sector in India.

  • Minimum Application Amount – First investment Rs. 5000/- and multiples of Rs. 1/- thereafter.

  • Plan/ Options available – Regular Plan and Direct Plan having Growth Option & Dividend Option.

  • Fund Managers – Pradeep Gokhale, Atul Bhole and Rupesh Patel

  • Benchmark – CNX Pharma Index

( Mutual Fund investments are subject to market risks, read all scheme related documents carefully.)

Locate Tata Mutual Fund Advisors in your city
comments powered by Disqus
Feedback